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Abstract  
Background: Catalase (CAT, OMIM: 115500) plays an integral role in the primary defence against 
oxidative stress. The T allele of the C-262T CAT polymorphism (rs1001179) is associated with 
lower activity of CAT. Here we investigated whether polymorphism of C-266T CAT was associated 
with susceptibility to schizophrenia. 
Methods: The present study was performed on 363 (267 males, 96 females) in-patients with 
schizophrenia diagnosis, and a total of 363 (266 males, 97 females) healthy controls. The C-262T 
CAT genotypes were determined using RFLP-PCR method.  
Results: Although the association between genotypes and susceptibility was not significant in both 
genders, there was significant interaction between gender and the TT genotype (P=0.035). The 
Log-rank test and the Kaplan-Meier survival analysis were used to evaluate the influence of C-262T 
genotypes on age at diagnosis (AAD) of schizophrenia. Mean AAD of the CC and CT+TT 
genotypes in males was 22.8 and 24.9 years, respectively. The difference was significant (
2
=4.26, 
P=0.039). Difference of mean AAD of the CC (26.7 years) and CT+TT (27.3 years) genotypes 
among females was not significant (
2
=0.02, P=0.896).  
Conclusion: Different associations between gender groups might be at least in part interpreted by 
the effect of gender on the association between C-262T polymorphism and CAT gene expression. 
  
 
 
 
 
 
Introduction 
While reactive oxygen species (ROS) are 
generated under physiological conditions, excess 
generation of ROS has pathological consequences. 
Oxidative stress is the condition arising from 
imbalance between toxic ROS and antioxidant 
systems. Oxidative stress may play a significant role 
in the risk of chronic diseases such as schizophrenia 
[1, 2]. 
Catalase (EC 1.11.1.6, CAT, OMIM: 115500) 
catalyzes the decomposition of H2O2 to O2 and H2O. 
Working together with other antioxidant enzymes, 
CAT plays an integral role in the primary defense 
against oxidative stress. Thus it limits the deleterious 
effects of ROS. A C/T polymorphism located 262 bp 
upstream to the CAT transcription site (C-262T, 
dbSNP rs1001179) has been described [3]. The less 
common T allele is associated with lower levels of red 
blood cell CAT activity [3, 4] which may increase ROS 
formation and oxidative stress.  
Several studies indicated that the 
polymorphism of C-262T CAT is associated with some 
multifactorial diseases [5-10]. At present we know that 
chronic exposure to excess ROS may contribute to 
brain damage and pathophysiology of schizophrenia 
[1, 2, 11, 12], CAT involved in detoxification of ROS 
[5-10], and C-262T polymorphism is associated with 
CAT activity [3, 4]. Taken together, these findings 
sufficiently provide us with a theoretical ration to 
investigate the association between CAT C-262T 
polymorphism and susceptibility to schizophrenia.   
 
Materials and Methods 
Study Subjects  
This case-control study was performed in 
Shiraz, south of Iran. Three hundred and sixty three 
schizophrenia in-patients (267 males, 96 females) 
from Ibn-Sina and Razi Hospitals, Shiraz University of 
Medical Sciences, (mean age + SD, 41.4 + 13.1 
years) participated in the study. The patients were 
chronic cases. Each face-to-face interview was 
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conducted by three psychiatrics. Inclusion criteria for 
patients were being aged between 16-65 years and 
having chronic schizophrenia. The patients were 
diagnosed as chronic schizophrenia according to 
structured clinical interview using SCID-I (clinician 
version) to confirm and document DSM-IV diagnosis. 
These patients had no other psychiatric disorder; 
including schizoaffective disorder, major depressive, 
episode with psychotic features, substance misuse, 
bipolar disorder, or mental retardation. A total of 363 
(266 males, 97 females) healthy blood donors (with no 
history of psychiatric disorders, cancers, asthma, 
cataract, psychotic disorder including schizophrenia, 
bipolar disorder, major depressive) matched with the 
patients according to age and gender was also 
studied, as a control group (mean age + SD, 39.7 + 
11.1 years). Table 1 shows the socio-demographic 
characteristics of the cases and controls.  
Considering the high heterogeneity of Iranian 
population [13, 14], the participants (patients and 
controls) were selected from Persian Muslims 
(Caucasians) living in Fars province (southern Iran). 
At the time of blood donation, a brief questionnaire 
that ascertained smoking status, age, history of 
cancers and asthma, was completed. This study was 
approved by the local ethics committee.  Informed 
consent was completed for each subject before the 
study. 
The study is more than sufficiently powered 
with an N=726 to detect a small-medium effect in 
allelic frequency between the two groups. Using the 
GPOWER software (version 2.0), to detect a real 
difference in allelic frequency with a power of 0.95 
(=0.01), df=1, Lambda=17.84, and an effect size of 
0.2; a minimum sample of 446 would be necessary. 
 
Extraction of DNA and C-262T CAT 
genotyping 
Blood samples were obtained from patient 
and control groups. Immediately after collection, 
whole blood was stored at -20ºC until use. Genomic 
DNA for PCR was isolated from whole blood using the 
thawed blood samples. The C-262T CAT genotypes 
were determined by PCR-RFLP method [10]. To test 
for contamination, negative controls (tubes containing 
the PCR mixture, without the DNA template) were 
incubated in every run. Any sample with ambiguous 
result due to low yield was retested and a random 
selection of 15% of all samples was repeated. No 
discrepancies were discovered upon replicate testing. 
 
Statistical analysis 
The comparison of genotypes of C-262T CAT 
polymorphisms between the gender groups was done 
by 
2
 test. Hardy-Weinberg equilibrium was assessed 
with the Chi-square test. The association between the 
C-262T CAT polymorphism and the development of 
schizophrenia was examined by use of the odds ratios 
(OR) and 95% of confidence intervals (CIs). The Cox 
regression analysis were used to evaluate the 
influence of C-262T CAT genotypes on age at 
diagnosis (AAD) of schizophrenia. Age at diagnosis 
was considered as time in the Cox regression 
analysis. Statistical analysis was performed using 
SPSS statistical software package (version 11.5). A 
probability of P<0.05 was considered statistically 
significant. All P values were two-tailed. 
 
Results  
Table 1 shows the socio-demographic 
characteristics of the cases and controls. There were 
significant differences between cases and controls for 
smoking status, education level and marital status. 
The patients were more smokers, single and have 
lower education.  
Table 1: The socio-demographic characteristics of the case 
and control groups. 
Variables Cases Controls 
Results of 
comparisons 
 
Continuous 
variable 
    
Age 41.4 + 13.1 39.7 + 11.1 t= 1.89 P=0.1 
Age of onset  24.3 + 8.6 - - - 
     
Discontinuous variables     
Sex     
Females 95 97   
Males 268 266 

2
=0.03 
(df=1) 
P=0.866 
     
Smoking Status     
Non-smokers 146 266   
Smokers 189 87 

2
=81.1 
(df=2) 
P<0.001 
Missing data 28 10   
     
Educational level     
Illiteracy 59 9   
Primary school 50 51   
High school 171 198   
College 31 80 

2
=69.8 
(df=4) 
P<0.001 
Missing data 52 50   
     
Marital status     
Single 232 58   
Married 122 289 

2
=174.2 
(df=2) 
P<0.001 
Missing data 9 16   
 
 
Table 2 shows the prevalence of genotypes of 
the C-262T CAT polymorphism in cases and controls. 
The prevalence of the genotypes among controls (For 
males: 
2
=0.30, df=1, P=0.584; For females 
2
=1.11, 
df=1, P=0.290) and patients (For males: 
2
=1.33, 
df=1, P=0.248; For females 
2
=0.67, df=1, P=0.412) 
were consistent with those expected from the Hardy-
Weinberg equilibrium. Considering that there is 
significant difference between gender groups of the 
patients for the genotypes (
2
=9.02, df=2, P=0.011), 
the gender groups were not pooled.  
Pearson Chi-square test showed that there 
was no difference between cases and controls for 
distribution of CAT genotypes among males (
2
=4.44, 
df=2, P=0.108) and females (
2
=2.27, df=2, P=0.321). 
There was no significant association between 
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genotypes (CT and TT) and risk of schizophrenia 
among males subjects (For CT vs CC: OR=0.77, 
95%CI: 0.54-1.11, P=0.171; For TT vs CC: OR=0.44, 
95% CI: 0.17-1.12, P=0.086). There was significant 
linear trend for presence of 0, 1 and 2 the C allele and 
schizophrenia risk among males (
2
=4.16, P=0.041). 
Among females, there was no association between 
genotypes and risk of schizophrenia (For CT vs CC: 
OR=0.90, 95%CI: 0.50-1.64, P=0.754; For TT vs CC: 
OR=2.33, 95% CI: 0.67-8.07, P=0.179) (Table 2).  
Table 2: Genotypic frequency of C-262T CAT in schizophrenia 
patients and healthy subjects. 
Polymorphism/ 
Gender 
Cases 
N (%) 
Control 
N (%) 
OR 95% CI 
P-
Value 
Males      
CC 172 (64.2) 151 (56.8) 1.0 - - 
CT 89 (33.2) 101 (38.0) 0.77 0.54-1.10 0.161 
TT 7 (2.6) 14 (5.2) 0.43 0.17-1.11 0.084 
CT+TT 96 (35.8) 115 (43.2) 0.73 0.51-1.03 0.080 
      
Females      
CC 51 (53.7) 53 (54.1) 1.0 - - 
CT 35 (36.8) 40 (40.8) 0.90 0.50-1.64 0.754 
TT 9 (9.5) 4 (4.1) 2.33 0.67-8.07 0.179 
CT+TT 44 (46.3) 44 (44.9) 1.03 0.58-1.83 0.894 
      
Total      
CC 223 (61.4) 204 (56.2) 1.0 - - 
CT 124 (34.2) 141 (38.8) 0.80 0.59-1.09 0.165 
TT 16 (4.4) 18 (5.0) 0.81 0.40-1.63 0.562 
CT+TT 140 (38.6) 159 (43.8) 0.80 0.59-1.08 0.152 
 
 
It should be noted that although the 
association between genotypes and susceptibility was 
significant neither in males nor in females, there was 
significant interaction between gender and the TT 
genotype (P=0.035).  
 
Figure 1: Association between genotypes of C-262T CAT 
polymorphism and age at diagnosis of schizophrenia among male 
patients. 
 
The Cox regression analysis were used to 
evaluate the influence of C-262T CAT genotypes on 
age at diagnosis (AAD) of schizophrenia. The AAD 
was considered as time in the Cox regression 
analysis. Among male subjects mean AAD of the CC 
and CT+TT genotypes were 22.8 and 24.9 years, 
respectively. Using Cox proportional hazards 
regression model, there were significant association 
between the CAT polymorphism and AAD of 
schizophrenia, after adjusted for smoking status of 
participants. The CC genotype versus to the CT + TT 
genotypes showed lower age at diagnosis of 
schizophrenia (HR=0.71, 95% CI: 0.51-0.99, 
P=0.043). Figure 1 showed the difference of age at 
diagnosis of schizophrenia between genotypes of the 
C-262T CAT polymorphism, among males. Difference 
of mean AAD of the CC (26.7 years) and CT+TT (27.3 
years) genotypes among females was not significant 
(HR=0.99, 95% CI: 0.55-1.78, P=0.989).  
 
Discussion 
It is suggested that oxidative stress may have 
a role in etiopathogenesis of schizophrenia [1, 2]. It 
has been shown that the polymorphism of C-262T 
CAT was associated with the expression and activity 
of CAT [3]. The less common T allele is associated 
with lower level of CAT activity [3, 4] which may 
increase ROS formation and oxidative stress. 
Therefore, we hypothesized that the TT genotype 
compared with the CC genotype increased the risk of 
schizophrenia. However, in the present study we 
found that there was no significant association 
between the CAT genotypes and risk of schizophrenia 
among subjects (Table 2). This finding is not 
consistent with the CAT activity in TT genotype 
compared with the CC genotype [3, 4]. 
Although the association between genotypes 
and susceptibility was not significant neither in males 
nor in females, there was significant interaction 
between gender and the TT genotype (P=0.035). 
Different associations between gender groups might 
be at least in part interpreted by the effect of gender 
on the association between C-262T polymorphism 
and CAT gene expression [15].  
The key finding of the present study is the 
significant difference between CC and CT+TT 
genotypes for age at diagnosis (AAD) of 
schizophrenia among male patients. AAD was lower 
in the CC genotype compared with the CT+TT 
genotypes. On the other hand, there was no 
difference between CAT genotypes for AAD among 
female patients. This difference at least in part might 
be interpreted with the effect of gender on the 
association between C-262T polymorphism and CAT 
gene expression [15].  
Considering that the magnitude of the 
alteration of CAT activity may depend on several 
factors such as race and diet [15-17], and the fact that 
ethnicity may influence the associations in 
multifactorial disease [18-21], replication of this study 
(with larger sample size) in other countries is 
recommended. 
 
 
Saadat et al. Genetic Polymorphism of C-262T Catalase and Schizophrenia 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
OA Maced J Med Sci. 2014 Mar 15; 2(1):74-77.                                                                                                                                                                               77 
 
Acknowledgements 
The authors are indebted to the participants 
for their close cooperation. The authors are indebted 
to Dr. Hasan Farrashbandi for introducing the 
patients. This study was supported by Shiraz 
University.   
 
References 
1. Yao JK, Reddy R., McElihnny LC, van Kammen DP. Reduced 
status of plasma total antioxidant capacity in schizophrenia. 
Schizophr Res. 1998;32:1-8. 
2. Reddy R, Keshavan M, Yao JK, Reduced plasma antioxidants in 
first-episode patients with schizophrenia. Schizophr Res. 
2003;62:205-211. 
3. Forsberg L, Lyrenas U, De Faire R, Mortgenstern A. A common 
functional C-T substitution in the promoter region of the human 
catalase gene influences transcription factor binding, reporter gene 
transcription and is correlated to blood catalase levels. Free Radic 
Biol Med. 2001;30:500-505. 
4. Ambrosone CB, Ahn J, Singh KK, Rezaishiraz H, Furberg H, 
Sweeney C, Coles B, Trovato A. Polymorphisms in genes related to 
oxidative stress (MPO, MnSOD, CAT) and survival after treatment 
for breast cancer. Cancer Res. 2005;65:1105-1111. 
5. Tefik T, Kucukgergin C, Sanli O, Oktar T, Seckin S, Ozsoy C. 
Manganese superoxide dismutase Ile58Thr, catalase C-262T and 
myeloperoxidase G-463A gene polymorphisms in patients with 
prostate cancer: relation to advanced and metastatic disease. BJU 
Int. 2013;112:E406-414.  
6. Khodayari S, Salehi Z, Fakhrieh Asl S, Aminian K, Mirzaei Gisomi 
N, Torabi Dalivandan S. Catalase gene C-262T polymorphism: 
importance in ulcerative colitis. J Gastroenterol Hepatol. 
2013;28:819-822.  
7. Yang LL, Huang MS, Huang CC, Wang TH, Lin MC, Wu CC, 
Wang CC, Lu SH, Yuan TY, Liao YH, Ko YC, Wang TN. The 
association between adult asthma and superoxide dismutase and 
catalase gene activity. Int Arch Allergy Immunol. 2011;156:373-380.  
8. Li Y, Ambrosone CB, McCullough MJ, Ahn J, Stevens VL, Thun 
MJ, Hong CC. Oxidative stress-related genotypes, fruit and 
vegetable consumption and breast cancer risk. Carcinogenesis. 
2009;30:777-784.  
9. Bohanec Grabar P, Logar D, Tomsic M, Rozman B, Dolzan V. 
Genetic polymorphisms modifying oxidative stress are associated 
with disease activity in rheumatoid arthritis patients. Dis Markers. 
2009;26:41-48.  
10. Zarbock R, Hendig D, Szliska C, Kleesiek K, Götting C. 
Pseudoxanthoma elasticum: genetic variations in antioxidant genes 
are risk factors for early disease onset. Clin Chem. 2007;53:1734-
1740. 
11. Zhang M, Zhao Z, He L, Wan C. A meta-analysis of oxidative 
stress markers in schizophrenia. Sci China Life Sci. 2010;53:112-
124.  
12. Bitanihirwe Byron KY, Woo Tsun-Ung W. Oxidative stress in 
schizophrenia: An integrated approach. Neurosci Biobehav Rev. 
2011;35:878-893. 
13. Mohamadynejad P, Saadat M. Genetic polymorphisms of 
XRCC1 (at codons 194 and 399) in Shiraz population (Fars 
province, southern Iran). Mol Biol Rep. 2008;35:669-672. 
14. Rafiee L, Saadat I, Saadat M. Glutathione S-transferase genetic 
polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian 
populations. Mol Biol Rep. 2010;37:155-158. 
15. Ahn J, Nowell S, McCann SE, Yu J, Carter L, Lang NP, 
Kadlubar FF, Ratnasinghe LD, Ambrosone CB. Association 
between catalase phenotype and genotype: modification by 
epidemiologic factors. Cancer Epidemiol Biomarkers Prev. 
2006;15:1217-1222. 
16. Nadif R, Mintz M, Jedlicka A, Bertrand JP, Kleeberger SR, 
Kauffmann F. Association of CAT polymorphisms with catalase 
activity and exposure to environmental oxidative stimuli. Free Radic 
Res. 2005;39:1345-1350. 
17. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, 
Teitelbaum SL, Terry MB, Nowell S, Davis W, Garza C, Neugut AI, 
Ambrosone CB. Associations between breast cancer risk and the 
catalase genotype, fruit and vegetable consumption, and 
supplement use. Am J Epidemiol. 2005;162:943-952. 
18. Goode EL, Ulrich CM, Potter JD, Polymorphisms in DNA repair 
genes and associations with cancer risk. Cancer Epidemiol 
Biomarkers Prev.  2002;11:1513-1530. 
19. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymorphisms 
and cancer risk: a meta-analysis of 38 case-control studies. Cancer 
Epidemiol Biomarkers Prev. 2005;14:1810-1818.  
20. Saadat M. Genetic polymorphisms of glutathione S-transferase 
T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. 
Cancer Sci. 2006:97:505-509. 
21. Saadat M, Ansari-Lari M. Polymorphism of XRCC1 (at codon 
399) and susceptibility to breast cancer, a meta-analysis of the 
literatures. Breast Cancer Res Treat. 2009;115:137-144. 
